Feed HLYK
HL

HealthLynked Corp. HLYK · OTC

$2.09 +0.62% (+$0.01)

Summary

16 / 100 · Bulios Score

What speaks for it

None of the indicators we track stands out on the positive side.

What to watch

  • Revenue fell by 29% a year over the last 3 years.
  • The company made a loss over the last 12 months.
  • It passes only 3 of the 9 points of the Piotroski financial health test.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

Revenue fell by 20% a year over 5 years. Over the last 3 years it fell by 29% a year.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $3.97M.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

Fiscal year 2022

By product

By region

ACOMCOMember brings in 100% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.